No company description available.
The Principal Medical Writer will support 4D-150, a gene therapy in late-stage development for retinal vascular diseases, including nAMD and DME, and associated BLA-enabling activities as well as clinical stage work within the lung program. This role is responsible for the planning, development, and delivery of high-quality clinical and regulatory documents across late-stage development, working closely with Clinical Science, Clinical Operations, Data Science, Regulatory Affairs, Quality, and external partners.
MJH Life SciencesÂź